BEXIMCO PHARMA.GDR REGS 1 (R2WA) — Net Asset Momentum
BEXIMCO PHARMA.GDR REGS 1 (R2WA) recorded a net asset momentum of 9.0% as of June 2024, with net assets of €51.90 Billion EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See how many days can BEXIMCO PHARMA.GDR REGS 1 fund operations to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
BEXIMCO PHARMA.GDR REGS 1 Net Asset Momentum (2021–2024)
This chart tracks BEXIMCO PHARMA.GDR REGS 1's year-over-year net asset growth across 4 annual reporting periods from 2021 to 2024. The most recent momentum reading is +9.0%, with net assets of €51.90 Billion EUR as of June 2024. Read BEXIMCO PHARMA.GDR REGS 1 debt and liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for BEXIMCO PHARMA.GDR REGS 1 (2021–2024)
The table below shows the complete annual net asset history for BEXIMCO PHARMA.GDR REGS 1 from 2021 to 2024, covering 4 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see how much is BEXIMCO PHARMA.GDR REGS 1 worth.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | €51.90 Billion | €69.34 Billion | €17.44 Billion | ▲ +9.0% |
| 2023 | €47.62 Billion | €69.16 Billion | €21.54 Billion | ▲ +6.7% |
| 2022 | €44.64 Billion | €66.15 Billion | €21.51 Billion | ▲ +19.5% |
| 2021 | €37.36 Billion | €52.25 Billion | €14.88 Billion | — |